Insider Transactions in Q3 2024 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2024
|
Varda Shalev |
BUY
Exercise of conversion of derivative security
|
Direct |
12,872
+50.0%
|
-
|
|
Aug 12
2024
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
98,943
-100.0%
|
$1,682,031
$17.3 P/Share
|
|
Aug 09
2024
|
Angus Grant EVP, Business Development |
SELL
Open market or private sale
|
Direct |
4,065
-31.48%
|
$69,105
$17.28 P/Share
|
|
Aug 09
2024
|
Angus Grant EVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,913
+50.0%
|
-
|
|
Aug 09
2024
|
Eric A Hughes |
SELL
Open market or private sale
|
Direct |
45,060
-100.0%
|
$766,020
$17.38 P/Share
|
|
Aug 01
2024
|
Eric A Hughes |
SELL
Open market or private sale
|
Direct |
24,537
-35.26%
|
$417,129
$17.25 P/Share
|
|
Aug 01
2024
|
Eric A Hughes |
BUY
Exercise of conversion of derivative security
|
Direct |
52,742
+43.11%
|
-
|